US2017275687A1PendingUtilityA1
Nucleic acid sequencing by electrochemical detection
Est. expiryAug 5, 2031(~5 yrs left)· nominal 20-yr term from priority
C12Q 1/6869G01N 27/3275G01N 27/333C12Q 2565/607G01N 27/44756Y02A50/30G01N 27/447
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein is technology relating to sequencing nucleic acids and particularly, but not exclusively, to devices, methods, and systems for sequencing-by-synthesis using changes in pH to monitor base addition.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A device for determining the sequence of a nucleic acid, the device comprising a reaction vessel comprising a hydrogen ion-sensitive electrode in contact with a sample comprising the nucleic acid, wherein the hydrogen ion-sensitive electrode is either:
a) a microfabricated metal oxide electrode comprising:
i) an insulating material sensitive to hydrogen ions; and
ii) a conductive metal oxide;
wherein the microfabricated metal oxide electrode does not exhibit the bulk conductive properties of the conductive metal oxide; or
b) a membrane electrode comprising:
i) a photolithographic base layer; and
ii) a hydrogen ion-sensitive membrane;
wherein the nucleic acid coats the surface of one or more microparticles in an electrode well compartment.
2 . The device of claim 1 further comprising a reference electrode.
3 . The device of claim 1 wherein the reaction vessel is a cylinder having a diameter of approximately 200 μm or less and a height of approximately 30 μm or less.
4 . The device of claim 1 wherein the hydrogen ion-sensitive electrode detects changes in pH greater than or equal to 0.1.
5 . The device of claim 1 comprising a plurality of hydrogen ion-sensitive electrodes.
6 . The device of claim 1 comprising a plurality of nucleic acids covering the one or more particles in an electrode well compartment at a density equal to or greater than 2.2×10 10 molecules/cm 2 .
7 . The device of claim 1 wherein the insulating material has a density of hydrogen ion binding sites that is greater than 10 13 /cm 2 .
8 . The device of claim 1 wherein the insulating material is selected from the group consisting of tantalum oxide, zirconium oxide, and aluminum oxide.
9 . The device of claim 1 wherein the conductive metal oxide is selected from the group consisting of iridium oxide, ruthenium oxide, platinum oxide, palladium oxide, rhodium oxide, and osmium oxide.
10 . The device of claim 1 comprising a clonal plurality of nucleic acids.
11 . The device of claim 1 wherein the hydrogen ion sensitive membrane comprises:
a) a solvent mixture comprising cyclohexanone and propiophenone;
b) sodium tetraphenylborate
c) tridodecyl amine;
d) dibutyl sebacate or o-nitrophenyloctylether; and
e) high-molecular weight polyvinylchloride.
12 . A method for determining the sequence of a nucleic acid, the method comprising:
a) providing a reaction solution comprising:
1) the nucleic acid;
2) a polymerase; and
3) an oligonucleotide complementary to the nucleic acid;
b) adding a deoxynucleotide to the reaction solution; and c) monitoring the pH of the reaction solution using a device according to claim 1 , wherein a change in the pH of the reaction solution indicates that the deoxynucleotide was polymerized to the 3′ end of the oligonucleotide.
13 . The method of claim 12 further comprising:
d) removing the deoxynucleotide from the reaction solution or inactivating the deoxynucleotide.
14 . A system for sequencing a nucleic acid comprising:
i) a device according to claim 1 comprising a cartridge and ii) a hand-held reading apparatus.
15 . The system of claim 14 wherein the cartridge comprises:
1) a hydrogen ion-sensitive electrode; and
2) a first interface component configured to mate with the reading apparatus and communicate with the reading apparatus; and
wherein the reading apparatus comprises:
1) a second interface component configured to mate with the cartridge and communicate with the cartridge; and
2) a microprocessor configured to receive data from the cartridge.
16 . The system of claim 15 wherein the data is raw data or transformed data.
17 . The system of claim 14 further comprising a user interface.
18 . The system of claim 15 wherein the data indicates the presence of a medical condition in a subject.
19 . The system of claim 15 wherein the data indicates the absence of a medical condition in a subject.
20 . A device for determining the sequence of a nucleic acid, the device comprising a reaction vessel comprising a hydrogen ion-sensitive electrode in contact with a sample comprising the nucleic acid, wherein the hydrogen ion-sensitive electrode is either:
a) a microfabricated metal oxide electrode comprising:
i) an insulating material sensitive to hydrogen ions; and
ii) a conductive metal oxide;
wherein the microfabricated metal oxide electrode does not exhibit the bulk conductive properties of the conductive metal oxide; or b) a membrane electrode comprising:
i) a photolithographic base layer; and
ii) a hydrogen ion-sensitive membrane;
wherein the nucleic acid comprises a plurality of nucleic acids covering one or more microparticles in an electrode well compartment.Join the waitlist — get patent alerts
Track US2017275687A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.